Retina Today

Retina Today delivers the latest research and clinical developments in medical retina, retinal surgery, vitreous, diabetes, & imaging. A BMC Vision publication.

[Retina Today @RetinaToday]

Good vision can mask active proliferative disease. This Visually Speaking case shows how widefield imaging revealed critical peripheral clues in a patient with diabetic retinopathy. Read more here: https://t.co/rdtvUkIerc

#RetinaToday #OCTA #DiabeticRetinopathy

[Retina Today @RetinaToday]

𝙍𝙚𝙩𝙞𝙣𝙖 𝙏𝙤𝙙𝙖𝙮 ’s October issue is a special edition: AI in the Retina Clinic. Chatbots, documentation, the OR, trial screening, and why the goal is a digital copilot, not autopilot.
Read the October issue: https://t.co/70s3v3sHC6 #Ophthalmology

[Retina Today @RetinaToday]

Catch up on the best of Euretina 2026 with our Eyetube video meeting coverage! Learn about gene therapies, TKIs, tamponades, novel retinal implants, and more.

Catch up here: https://t.co/604zzoCvqw

[Retina Today @RetinaToday]

Dr. Carl Danzig says picking a treatment is easy—you just have to get patients in the chair who agree to treatment in the first place. What methods does he employ to get patients to where they need to be?

Check out the new Eyetube series GA in Practice: https://t.co/SI8tJNbW79

[Retina Today @RetinaToday]

Supporting patients with GA goes beyond discussing disease progression. Priya Vakharia, MD, FASRS, shares practical strategies for counseling, preparing for functional changes, and helping patients maintain independence throughout their GA journey: https://t.co/BqhWcxxoRP

[Retina Today @RetinaToday]

Alexis Warren, MD, is One to Watch in Retina! 🎉 She was inspired to pursue retina as a young child shadowing her father in the clinic. Read about Dr. Warren’s path to retina, her key mentors, and pearls for new surgeons: https://t.co/Zl0KmPemf9

[Retina Today @RetinaToday]

Most vitreous hemorrhages from a PVD clear on their own—but 17% come with a retinal detachment hiding underneath, most within the first 3 weeks. 👁️ Barton Blackorby, MD; Matt Starr, MD; and Kyle Kovacs, MD, discuss when to watch and when to operate: https://t.co/XulXGghGLK

[Retina Today @RetinaToday]

How are you integrating advanced imaging and surgical technology into your practice? Kat Talcott, MD, and Jorge Fortun, MD, share how the Zeiss Retina Workflow keeps them organized and efficient in the clinic and OR.

Learn more at: https://t.co/UN9PDfMz9p #ad

[Retina Today @RetinaToday]

In PVR surgery, the goal is not only to reattach the retina, but to protect the macula at every step. Surgical pearls from Drs. Shah and Anguita: https://t.co/osbekWIq73 #Ophthalmology #Vitreoretinopathy

[Retina Today @RetinaToday]

When anti-VEGF therapy isn't enough for DME, what comes next? Drs. Pfannenstiel and Clevenger review approved and emerging implant-based treatments for diabetic retinopathy and diabetic macular edema. https://t.co/Gntx5sbe8Z #Retina #DME

[Retina Today @RetinaToday]

We had a blast in Vienna at Euretina 2026! The exhibit hall was bustling, the sessions were packed, and our booth was swarmed! We cannot wait to give out more “We Love Retina” bags at FLORetina in December. #retina #Euretina2026

[Retina Today @RetinaToday]

Which patients with geographic atrophy may be appropriate candidates for complement inhibition? Explore key considerations for treatment selection, including disease characteristics and patient factors: https://t.co/7PMgym3Agp

This article is available to our ex-US audiences.

[Retina Today @RetinaToday]

Up to 35% of patients with DME gained fewer than 5 letters at 12 weeks on monthly aflibercept 2 mg in the Protocol T early analysis. Where could TKIs fit? https://t.co/kwZRON2kpC
#Ophthalmology

[Retina Today @RetinaToday]

👁️ This World Retina Day, we celebrate the advances shaping retinal care. But can we do more to detect diabetic eye disease earlier? Experts from around the world explore the challenges of global screening—and the opportunities ahead. Read more: https://t.co/1Ek6ddH9yj

[Retina Today @RetinaToday]

Can OCTA predict DR progression? Kallista Zhuang, BA, Shinji Kakihara, MD, PhD, and Amani A. Fawzi, MD review the evidence in Retina Today's Sept issue. Read: https://t.co/1lXd43nNA9 #RetinaResearch #Ophthalmology

[Retina Today @RetinaToday]

We're thrilled to be in sunny Los Angeles ☀️ for a fantastic scientific program at the #RetinaSociety2026 annual meeting! #retina

[Retina Today @RetinaToday]

From SOL-1 and TRUCKEE to OCU410 in GA and Stargardt and real-world YAG data, New Retina Radio recaps key findings from #ASRS 2026, highlighting the latest advances and real-world insights in retina.

Listen now: https://t.co/3DpP0etHyd

[Retina Today @RetinaToday]

Nanoscope said Dr. Christine Kay will present 4-year MCO-010 data from the RESTORE trial for retinitis pigmentosa at the Retina Society meeting in Los Angeles.

https://t.co/8FxlvbJcYp"

[Retina Today @RetinaToday]

AI's role in DME is moving from research to real-world practice. Scott Song, BA, and T.Y. Alvin Liu, MD, break down the data in this month's 𝑅𝑒𝑡𝑖𝑛𝑎 𝑇𝑜𝑑𝑎𝑦. Read: https://t.co/teWCWELk35 #Ophthalmology #ClinicalPractice #AIInMedicine

[Retina Today @RetinaToday]

In the latest episode of Formula Retina, leading surgeons explore how UNITY VCS is advancing vitreoretinal surgery. They discuss the platform’s innovative technology, intelligent fluidics, IOP control, illumination, 27-gauge vitrectomy, and more: https://t.co/OnwJ6ok1kd

[Retina Today @RetinaToday]

New data on AI in DME: A CFP-based screening model hit a 0.962 patient-level AUC, an AI-assisted OCT pathway cut false-positive referrals from 69.1% to 24.1%, and a multimodal model beat specialists at predicting anti-VEGF response — internally, at least.
https://t.co/F40FCRTBcx